Senseonics Holdings, Inc. (NYSE:SENS) to Post FY2024 Earnings of ($0.12) Per Share, HC Wainwright Forecasts

Senseonics Holdings, Inc. (NYSE:SENS - Free Report) - HC Wainwright cut their FY2024 earnings per share estimates for Senseonics in a report issued on Monday, March 11th. HC Wainwright analyst V. Bernardino now anticipates that the company will earn ($0.12) per share for the year, down from their previous forecast of ($0.08). The consensus estimate for Senseonics' current full-year earnings is ($0.12) per share. HC Wainwright also issued estimates for Senseonics' FY2025 earnings at ($0.08) EPS.

Separately, TheStreet cut Senseonics from a "c-" rating to a "d" rating in a research note on Friday, November 17th.

Senseonics Stock Performance

SENS remained flat at $0.56 during trading on Thursday. The company had a trading volume of 1,261,129 shares, compared to its average volume of 2,542,437. The company has a market capitalization of $299.72 million, a PE ratio of -5.09 and a beta of 0.90. The company has a debt-to-equity ratio of 1.15, a current ratio of 7.53 and a quick ratio of 7.03. Senseonics has a 1-year low of $0.46 and a 1-year high of $1.05. The business has a 50 day moving average price of $0.59.

Senseonics (NYSE:SENS - Get Free Report) last issued its quarterly earnings data on Thursday, February 29th. The company reported ($0.03) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.04) by $0.01. The company had revenue of $8.00 million for the quarter, compared to the consensus estimate of $7.62 million. Senseonics had a negative return on equity of 146.90% and a negative net margin of 270.13%.

Institutional Trading of Senseonics

Several large investors have recently modified their holdings of SENS. Magnolia Capital Advisors LLC purchased a new position in shares of Senseonics during the 4th quarter worth approximately $26,000. CTC Alternative Strategies Ltd. purchased a new position in shares of Senseonics during the 2nd quarter worth approximately $31,000. Cornerstone Wealth Management LLC grew its holdings in shares of Senseonics by 55.9% during the 3rd quarter. Cornerstone Wealth Management LLC now owns 55,750 shares of the company's stock worth $34,000 after acquiring an additional 20,000 shares during the period. RPO LLC purchased a new position in shares of Senseonics during the 4th quarter worth approximately $37,000. Finally, Stifel Financial Corp grew its holdings in shares of Senseonics by 38.9% during the 1st quarter. Stifel Financial Corp now owns 53,520 shares of the company's stock worth $38,000 after acquiring an additional 15,000 shares during the period. 16.59% of the stock is owned by institutional investors.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense, Eversense XL, and Eversense E3 which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months.